Renaissance Capital logo

BYSI News

BeyondSpring prices IPO at $20, the low end of the range

BeyondSpring logo

BeyondSpring, which is developing a cancer therapy to combat the loss of white blood cells, raised $3 million by offering 0.17 million shares at $20, the low end of the range of $20 to $22. BeyondSpring plans to list on the Nasdaq under the symbol BYSI. Rodman...read more

Cancer biotech BeyondSpring lowers deal size for tonight's IPO to $3 million, below our IPO cutoff

BeyondSpring logo

BeyondSpring, which is developing a cancer therapy to combat the loss of white blood cells, lowered the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $3 million by offering 0.1 million shares at a...read more

Cancer biotech BeyondSpring sets terms for a downsized $10 million IPO

BeyondSpring logo

BeyondSpring, which is developing a cancer therapy to combat the loss of white blood cells, announced terms for a $10 million IPO and $51 million concurrent private placement on Tuesday. The company originally filed for a $100 million offering in November...read more

US IPO Weekly Recap: 6 IPO filings signal a more active December

HUNTU

Sandwiched between the election and Thanksgiving, the US IPO market had another slow week for new offerings. Meanwhile, recent news and a string of initial filings signals that companies are preparing for IPOs in December and early 2017. Those plans...read more